Clin Mol Hepatol.
2020 Oct;26(4):489-491. 10.3350/cmh.2020.0228.
More evidence that direct acting antiviral therapy is safe and effective in cirrhosis and chronic kidney disease including peritoneal dialysis
- Affiliations
-
- 1Department of Gastroenterology and Hepatology, Stanford University, Redwood City, CA, USA
- KMID: 2507968
- DOI: http://doi.org/10.3350/cmh.2020.0228
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- New dialysis treatment options for patients with end-stage chronic kidney disease
- Peritoneal dialysis in children and adolescents
- Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals
- 2017 Korean Association for the Study of the Liver (KASL) Clinical Practice Guidelines of Chronic Hepatitis C: What's New?
- Kidney disease in patients with chronic liver disease
